Penserra Capital Management LLC Alaunos Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.09 - $1.89 $5,379 - $9,327	-4,935 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $43 - $81	30 Added 0.61%	4,935 $8,000
Q2 2021 Aug 12, 2021	BUY	$2.63 - $3.67 $92 - $128	35 Added 0.72%	4,905 $12,000
Q1 2021 May 13, 2021	SELL	$2.82 - $5.6 $126 - $251	-45 Reduced 0.92%	4,870 $17,000
Q4 2020 Feb 12, 2021	BUY	$2.09 - $3.09 $10,272 - $15,187	4,915 New	4,915 $12,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.